Keywords: astrazeneca, files, new, data, fda, crestor, possible

AstraZeneca files new data to US FDA on Crestor; possible approval in 2nd half

Article | 17 February 2003

Print This

AstraZeneca has submitted new data to the US Food and Drug Admnistrationin order to move forward the review procedure for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in